Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11
- PMID: 16504379
- DOI: 10.1016/j.canlet.2006.01.014
Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11
Abstract
The development of T cell-based immunotherapies of cancer depends on the identification of tumor-associated antigens capable of eliciting tumor-directed cytotoxic T cell responses. In malignant glioma the number of well-defined target antigens for cytotoxic T lymphocytes (CTLs) is still very limited. Recently, we demonstrated the abundant and specific overexpression of the transcription factor SOX11 in malignant glioma. Here, we describe the SOX11-derived peptide LLRRYNVAKV which is capable of inducing human leukocyte antigen-A*0201-restricted and tumor-reactive CTLs. This novel CTL epitope may serve as an attractive candidate for a T cell-based immunotherapy of glioma.
Similar articles
-
Identification of a WT1 protein-derived peptide, WT1, as a HLA-A 0206-restricted, WT1-specific CTL epitope.Microbiol Immunol. 2008 Nov;52(11):551-8. doi: 10.1111/j.1348-0421.2008.00069.x. Microbiol Immunol. 2008. PMID: 19090835
-
Identification and characterization of a WT1 (Wilms Tumor Gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes.J Immunother. 2007 Apr;30(3):282-93. doi: 10.1097/01.cji.0000211337.91513.94. J Immunother. 2007. PMID: 17414319
-
Identification of an HLA-A*0201 restricted Bcl2-derived epitope expressed on tumors.Cancer Lett. 2007 Jun 18;251(1):86-95. doi: 10.1016/j.canlet.2006.11.004. Epub 2006 Dec 19. Cancer Lett. 2007. PMID: 17182178
-
Functional idiotopes: tumor antigen-directed expression of CD8+ T-cell epitopes nested in unique NH2-terminal VH sequence of antiidiotypic antibodies?Cancer Res. 2005 Jul 15;65(14):6001-4. doi: 10.1158/0008-5472.CAN-04-3400. Cancer Res. 2005. PMID: 16024597 Review.
-
T cell epitope-specific immune therapy for rheumatic diseases.Arthritis Rheum. 2006 Jan;54(1):19-25. doi: 10.1002/art.21520. Arthritis Rheum. 2006. PMID: 16385493 Review. No abstract available.
Cited by
-
Cellular-based immunotherapies for patients with glioblastoma multiforme.Clin Dev Immunol. 2012;2012:764213. doi: 10.1155/2012/764213. Epub 2012 Feb 28. Clin Dev Immunol. 2012. PMID: 22474481 Free PMC article. Review.
-
Recent advances and future of immunotherapy for glioblastoma.Expert Opin Biol Ther. 2016 Oct;16(10):1245-64. doi: 10.1080/14712598.2016.1212012. Epub 2016 Jul 27. Expert Opin Biol Ther. 2016. PMID: 27411023 Free PMC article. Review.
-
A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy.J Immunol Res. 2014;2014:326545. doi: 10.1155/2014/326545. Epub 2014 Jun 9. J Immunol Res. 2014. PMID: 25009822 Free PMC article. Review.
-
Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens.Int J Mol Sci. 2023 Jan 24;24(3):2292. doi: 10.3390/ijms24032292. Int J Mol Sci. 2023. PMID: 36768616 Free PMC article.
-
Definition and Characterization of SOX11-Derived T Cell Epitopes towards Immunotherapy of Glioma.Int J Mol Sci. 2023 Jan 18;24(3):1943. doi: 10.3390/ijms24031943. Int J Mol Sci. 2023. PMID: 36768267 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials